View Clinical Trial (Medical Research Study)

Aberant Gene Expression Prostate Carcinoma - NCT00868803-01805(Clinical Trial 280342)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Burlington
State:  
MA
Zip Code: 01805
Conditions: Prostate Cancer
Purpose: The goal of the study is to gain a better understanding of the molecular changes responsible for causing prostate cancer and that examination of tissue and blood samples will help in the development of improved screening and therapeutic approaches.
Study summary: The goal of this study is to identify novel genetic elements that are aberantly expressed throughout prostatic neoplastic progression. The approaches proposed exploit the known familial arm of prostatic cancer, using established molecular genetic approaches, and extend these studies to sporadic prostatic cancer using a novel technique of differential display. Application of the latter technique to colon cancer in the American population establishes this tumor type as a high priority for scientific investigation and this study is part of an initiative to address this problem. Presently the studies in the field of prostate are under-represented. The collection of tissue samples from patients diagnosed with prostate cancer. Patients will also provide a blood sample at the time of their surgery and potentially post-op from 6 mos to 5 years. Samples will also be obtained from patients who's biopsy turns out to be non-prostate cancer. These samples will be obtained shortly following the biopsy out to 6 months after the biopsy.
Criteria: Inclusion Criteria: - Diagnosed prostate cancer undergoing prostatectomy - Suspicion of prostate cancer undergoing biopsy - negative biopsy - Health volunteer (control group) - blood sample for PSA Exclusion Criteria: - Patients not fitting the inclusion criteria
Study is available at: Lahey Clinic
Burlington, MA 01805
United States

Primary Contact:
JohN A Libertino, M.D.
Email: John.A.Libertino@Lahey.org
Phone: 781-744-2511

Secondary Contact:
John A Libertino, M.D.
Email: John.A.Libertino@Lahey.org
Phone: 781-744
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.